These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1857857)

  • 1. Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer.
    Schmid L; Thürlimann B; Müller M; Senn HJ
    Recent Results Cancer Res; 1991; 121():173-81. PubMed ID: 1857857
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
    Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
    Cancer Invest; 1993; 11(2):229-34. PubMed ID: 8462024
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
    Furman WL; Fairclough DL; Huhn RD; Pratt CB; Stute N; Petros WP; Evans WE; Bowman LC; Douglass EC; Santana VM
    J Clin Oncol; 1991 Jun; 9(6):1022-8. PubMed ID: 2033415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Hess U; Ganser A; Schnürch HG; Seipelt G; Ottmann OG; Falk S; Schulz G; Hoelzer D
    Br J Haematol; 1992 Feb; 80(2):254-6. PubMed ID: 1550786
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.
    Eguchi K; Kabe J; Kudo S; Mano K; Morinari H; Nakada K; Noda K; Saito Y; Tanaka T; Uzawa T
    Cancer Chemother Pharmacol; 1994; 34(1):37-43. PubMed ID: 8174201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.
    Yeung AW; Pang YK; Tsang YC; Wong SW
    Cancer; 1994 Apr; 73(7):1960-70. PubMed ID: 7511042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. The Multicenter Study Group.
    Miwa S; Shibata A; Kaneko T; Moriyama Y; Kaku K; Ishida Y; Takahashi M
    Acta Haematol; 1992; 87(1-2):22-8. PubMed ID: 1585768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study.
    Bergmann L; Karakas T; Knuth A; Lautenschläger G; Mitrou PS; Hoelzer D
    Eur J Cancer; 1995 Dec; 31A(13-14):2164-8. PubMed ID: 8652236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of recombinant granulocyte macrophage colony stimulating factor in patients with non-Hodgkin's lymphoma.
    Mughal TI; O'Neill K
    Leuk Lymphoma; 1994 Jul; 14(3-4):331-4. PubMed ID: 7950923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying hematopoiesis with colony-stimulating factors.
    Peters WP
    Am J Clin Pathol; 1992 May; 97(5):605-7. PubMed ID: 1575203
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 13. Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.
    Cabanillas F; Cotto M; Liboy I; Rivera E; Pavia OA; Bruno M
    Leuk Lymphoma; 2012 Oct; 53(10):1929-33. PubMed ID: 22448918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
    Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two phase I studies of carboplatin dose escalation in chemotherapy-naive ovarian cancer patients supported with granulocyte-macrophage colony-stimulating factor.
    Rusthoven J; Levin L; Eisenhauer E; Mazurka J; Carmichael J; O'Connell G; Bryson P; Hirte H; Koski B
    J Natl Cancer Inst; 1991 Dec; 83(23):1748-53. PubMed ID: 1770554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) to support intensive chemotherapy.
    Klingemann HG
    Prog Clin Biol Res; 1990; 354B():211-8. PubMed ID: 2236167
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 19. De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphoma.
    Seignez A; Casasnovas O; Ferrant E; Bastie JN; Mondoloni P; Aho LS; Boulin M
    Int J Clin Pharm; 2015 Dec; 37(6):1033-7. PubMed ID: 26408407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Betaleukin (human recombinant interleukin-1 beta)--a new effective leukopoiesis stimulant and protector in the combined chemotherapy of malignant tumors].
    Gershanovich ML; Filatova LV; Ketlinskiĭ SA; Simbirtsev AS
    Vopr Onkol; 2000; 46(3):354-60. PubMed ID: 10976287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.